Erratum: Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial

Rainer Fietkau

Michael Ghadimi

From Bielefeld University, Medical School and University Medical Center Ostwestfalen-Lippe, Campus Hospital Lippe, Detmold, Germany (J.H.); the Department of Radiation Oncology, Medical University of Graz, Graz, Austria (T.B.); the Clinical Trials Unit, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany (C.S.); the Institute of Surgical Pathology, University Medical Center Freiburg, Germany (P.B.); the Department of Surgery, University Medical Center Schleswig-Holstein–Campus Lübeck, Lübeck, Germany (B.K., T.K.); Comprehensive Cancer Center Augsburg, Faculty of Medicine, University of Augsburg, Augsburg, Germany (R.C.); the Department of General and Visceral Surgery, University Medical Center Freiburg, Freiburg, Germany (S.U.); the Department of General, Visceral, and Thoracic Surgery, University Medical Center Hamburg–Eppendorf, Hamburg, Germany (J.R.I.); the Department of Gastrointestinal Surgery, IRCCS San Raffaele Scientific Institute and San Raffaele Vita-Salute Universi...

Robert Grützmann

Uwe A. Wittel

Lutz Jacobasch

11Praxis of Haematology and Oncology, Dresden, Germany

Waldemar Uhl

Department of General and Visceral Surgery, St. Josef Hospital, Ruhr University, Bochum, Germany

Roland S. Croner

Wolf Otto Bechstein

Ulf Peter Neumann

From Bielefeld University, Medical School and University Medical Center Ostwestfalen-Lippe, Campus Hospital Lippe, Detmold, Germany (J.H.); the Department of Radiation Oncology, Medical University of Graz, Graz, Austria (T.B.); the Clinical Trials Unit, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany (C.S.); the Institute of Surgical Pathology, University Medical Center Freiburg, Germany (P.B.); the Department of Surgery, University Medical Center Schleswig-Holstein–Campus Lübeck, Lübeck, Germany (B.K., T.K.); Comprehensive Cancer Center Augsburg, Faculty of Medicine, University of Augsburg, Augsburg, Germany (R.C.); the Department of General and Visceral Surgery, University Medical Center Freiburg, Freiburg, Germany (S.U.); the Department of General, Visceral, and Thoracic Surgery, University Medical Center Hamburg–Eppendorf, Hamburg, Germany (J.R.I.); the Department of Gastrointestinal Surgery, IRCCS San Raffaele Scientific Institute and San Raffaele Vita-Salute Universi...

Dirk Waldschmidt

Stefan Boeck

Nicolas Moosmann

Anke C. Reinacher-Schick

COLOPREDICT Platform and Department of Hematology, Oncology and Palliative Care, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany

Henriette Golcher

Werner Adler

Rainer Fietkau, MD, Sabine Semrau, MD, and Annett Kallies, PhD, Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany, National Center for Tumor Diseases (NCT), NCT WERA, a Partnership Between DKFZ, and the Universities and University Hospitals in Wurzburg, Erlangen, Germany; Werner Adler, PhD, Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen-Nurnberg, Erlangen, Germany, Helmut Oettle, MD, Department of Hematology, Oncology, and Tumor Immunology, Charité—Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany

Sabine Semrau

Dorota Lubgan

Annett Kallies

Rainer Fietkau, MD, Sabine Semrau, MD, and Annett Kallies, PhD, Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany, National Center for Tumor Diseases (NCT), NCT WERA, a Partnership Between DKFZ, and the Universities and University Hospitals in Wurzburg, Erlangen, Germany; Werner Adler, PhD, Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen-Nurnberg, Erlangen, Germany, Helmut Oettle, MD, Department of Hematology, Oncology, and Tumor Immunology, Charité—Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany

Markus Hecht

Institute of Organic Chemistry

Iris Tischoff

Andrea Tannapfel

COLOPREDICT Platform and Institute of Pathology, Ruhr-University, Bochum, Germany

Benjamin Frey

Helmut Oettle

Rainer Fietkau, MD, Sabine Semrau, MD, and Annett Kallies, PhD, Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany, National Center for Tumor Diseases (NCT), NCT WERA, a Partnership Between DKFZ, and the Universities and University Hospitals in Wurzburg, Erlangen, Germany; Werner Adler, PhD, Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen-Nurnberg, Erlangen, Germany, Helmut Oettle, MD, Department of Hematology, Oncology, and Tumor Immunology, Charité—Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany